Εμφάνιση απλής εγγραφής

dc.creatorScholz J., Grossmann K., Knütter I., Hiemann R., Sowa M., Röber N., Rödiger S., Schierack P., Reinhold D., Bogdanos D.P., Meroni P.L., Radice A., Conrad K., Roggenbuck D.en
dc.date.accessioned2023-01-31T09:54:39Z
dc.date.available2023-01-31T09:54:39Z
dc.date.issued2015
dc.identifier10.1515/cclm-2015-0083
dc.identifier.issn14346621
dc.identifier.urihttp://hdl.handle.net/11615/78855
dc.description.abstractBackground: For the serological diagnosis of systemic autoimmune rheumatic diseases, a two-tier approach starting with sensitive antinuclear antibody (ANA) detection by indirect immunofluorescence (IIF) on HEp-2 cells followed by characterization of positive findings with different immunoassays is recommended. To overcome drawbacks of this approach, we developed a novel technique allowing the combination of screening and simultaneous confirmatory testing. For the first time, this creates the basis for second generation ANA testing. Methods: ANA and autoantibodies (autoAbs) to double-stranded DNA (dsDNA), CENP-B, SS-A/Ro52, SS-A/Ro60, SS-B/La, RNP-Sm, Sm, and Scl-70 were determined by IIF and enzyme-linked immunosorbent assay (ELISA), respectively, and compared to simultaneous analysis thereof by second generation ANA analysis in patients with systemic lupus erythematosus (n=174), systemic sclerosis (n=103), Sjögren's syndrome (n=46), rheumatoid arthritis (n=36), mixed and undetermined connective tissue diseases (n=13), myositis (n=21), infectious disease (n=21), autoimmune liver disease (n=93), inflammatory bowel disease (n=78), paraproteinemia (n=11), and blood donors (n=101). Results: There was very good agreement of second generation ANA testing with classical one by IIF and ELISA regarding testing for ANA and autoAbs to dsDNA, CENP-B, SS-B, RNP-Sm, Scl-70, SS-A/Ro52, and SS-A/Ro60 (Cohen's κ>0.8). The agreement for anti-Sm autoAb was good (κ=0.77). The differences of both approaches were not significant for autoAbs to SS-B/La, RNP-Sm, Scl-70, SS-A/Ro60, and SS-A/Ro52 (McNemar's test, p>0.05, respectively). Conclusions: Second generation ANA testing can replace the two-tier analysis by combining IIF screening with multiplex confirmative testing. This addresses shortcomings of classical ANA analysis like false-negative ANA findings and lack of laboratory efficiency and standardization. © 2015, Dirk Roggenbuck et al., published by De Gruyter 2015.en
dc.language.isoenen
dc.sourceClinical Chemistry and Laboratory Medicineen
dc.source.urihttps://www.scopus.com/inward/record.uri?eid=2-s2.0-84946882239&doi=10.1515%2fcclm-2015-0083&partnerID=40&md5=865f2bccefaeb09f50888b1f6386e431
dc.subjectantinuclear antibodyen
dc.subjectcentromere protein Ben
dc.subjectdouble stranded DNA antibodyen
dc.subjectLa antibodyen
dc.subjectRo antibodyen
dc.subjectscl 70 antibodyen
dc.subjectantinuclear antibodyen
dc.subjectadulten
dc.subjectageden
dc.subjectantibody detectionen
dc.subjectantibody screeningen
dc.subjectArticleen
dc.subjectautoimmune hepatitisen
dc.subjectautoimmune liver diseaseen
dc.subjectblood donoren
dc.subjectclinical assessmenten
dc.subjectconnective tissue diseaseen
dc.subjectcontrolled studyen
dc.subjectCrohn diseaseen
dc.subjectcytomegalovirus infectionen
dc.subjectenzyme linked immunosorbent assayen
dc.subjectEpstein Barr virus infectionen
dc.subjectfemaleen
dc.subjectHEp 2 cell lineen
dc.subjecthumanen
dc.subjectHuman immunodeficiency virus infectionen
dc.subjectimmunoassayen
dc.subjectimmunofluorescenceen
dc.subjectinfectionen
dc.subjectmajor clinical studyen
dc.subjectmaleen
dc.subjectmiddle ageden
dc.subjectmixed connective tissue diseaseen
dc.subjectmyositisen
dc.subjectparaproteinemiaen
dc.subjectprimary biliary cirrhosisen
dc.subjectprimary sclerosing cholangitisen
dc.subjectpriority journalen
dc.subjectrheumatoid arthritisen
dc.subjectserologyen
dc.subjectSjoegren syndromeen
dc.subjectsystemic lupus erythematosusen
dc.subjectsystemic sclerosisen
dc.subjectulcerative colitisen
dc.subjectvery elderlyen
dc.subjectAutoimmune Diseasesen
dc.subjectblooden
dc.subjectHepG2 cell lineen
dc.subjectimmunologyen
dc.subjectindirect fluorescent antibody techniqueen
dc.subjectRheumatic Diseasesen
dc.subjectAntibodies, Antinuclearen
dc.subjectAutoimmune Diseasesen
dc.subjectFluorescent Antibody Technique, Indirecten
dc.subjectHep G2 Cellsen
dc.subjectHumansen
dc.subjectImmunoassayen
dc.subjectRheumatic Diseasesen
dc.subjectWalter de Gruyter GmbHen
dc.titleSecond generation analysis of antinuclear antibody (ANA) by combination of screening and confirmatory testingen
dc.typejournalArticleen


Αρχεία σε αυτό το τεκμήριο

ΑρχείαΜέγεθοςΤύποςΠροβολή

Δεν υπάρχουν αρχεία που να σχετίζονται με αυτό το τεκμήριο.

Αυτό το τεκμήριο εμφανίζεται στις ακόλουθες συλλογές

Εμφάνιση απλής εγγραφής